Carole S. Ben-Maimon owns 0.50% of Larimar Therapeutics
524,054 shares as of the January 26, 2026 filing, worth $1M at the latest close.
LRMR · $206M market capGet an email when Carole S. Ben-Maimon’s stake moves.
Free.
The stake
0.50%
worth $1M at the latest close
Stake rank
#2,599
by dollar value of the stake
Last sale
None
no sales since 2022
Last buy
1,251 days ago
May 17, 2023 · $18,525
Carole S. Ben-Maimon owns 0.50% of Larimar Therapeutics, Inc.: 524,054 of 103,882,937 shares, worth about $1M at the 2026-10-16 close. The stake has moved from 0.00% in 2020 to 0.50% on 2026-03-17, across 0 sales and 2 purchases that moved it since 2016. The last trade that moved it was a discretionary purchase of $18,525 on 2023-05-17.
How the stake is held
as of the Jan 26, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated Jan 26, 2026 · Form 4 ↗
HELD DIRECTLY
368,276
70.3%
HELD INDIRECTLY · By Trust
155,778
29.7%
THE STAKE
524,054
0.50%